$47.85
+0.93 (+1.98%)
At Close: Jun 03, 2026
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
04:01pm, Tuesday, 12'th Nov 2024
LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London He
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript
11:45am, Tuesday, 29'th Oct 2024
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA ) Q3 2024 Earnings Conference Call October 29, 2024 8:30 AM ET Company Participants Jonathan Kirshenbaum - Investor Relations Sanj Patel - Chair
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 Loss, Tops Revenue Estimates
09:46am, Tuesday, 29'th Oct 2024
Kiniksa Pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.01.
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
07:30am, Tuesday, 29'th Oct 2024
– ARCALYST ® (rilonacept) Q3 2024 net product revenue of $112.2 million, representing 73% year-over-year growth – – ARCALYST 2024 expected net product revenue increased to $410 - $420 million �
Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024
04:01pm, Tuesday, 22'nd Oct 2024
LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 29, 2024 at
What Makes Kiniksa Pharmaceuticals (KNSA) a Good Fit for 'Trend Investing'
09:51am, Friday, 11'th Oct 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pharmaceuticals (KNSA) could be a great choice. It is one of the several stocks that passed through our
Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet
10:56am, Wednesday, 09'th Oct 2024
The consensus price target hints at a 42.3% upside potential for Kiniksa Pharmaceuticals (KNSA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ea
Kiniksa Pharmaceuticals (KNSA) is on the Move, Here's Why the Trend Could be Sustainable
09:56am, Friday, 20'th Sep 2024
Kiniksa Pharmaceuticals (KNSA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
04:01pm, Wednesday, 28'th Aug 2024
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Wells Fargo Healthc
Wall Street Analysts Believe Kiniksa Pharmaceuticals (KNSA) Could Rally 30.11%: Here's is How to Trade
11:01am, Monday, 05'th Aug 2024
The consensus price target hints at a 30.1% upside potential for Kiniksa Pharmaceuticals (KNSA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ea
5 Stocks With Recent Price Strength in a Volatile Market
08:22am, Friday, 02'nd Aug 2024
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are KNSA, HNI, AEYE, BCPC, GRC.
Best Momentum Stocks to Buy for August 1st
11:15am, Thursday, 01'st Aug 2024
CVNA, QCRH, and KNSA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 1, 2024.
New Strong Buy Stocks for August 1st
08:21am, Thursday, 01'st Aug 2024
NVCR, KGC, CVNA, KNSA and MU have been added to the Zacks Rank #1 (Strong Buy) List on August 1, 2024.
Kiniksa Pharmaceuticals, Ltd. (KNSA) Is Up 0.09% in One Week: What You Should Know
01:01pm, Friday, 26'th Jul 2024
Does Kiniksa Pharmaceuticals, Ltd. (KNSA) have what it takes to be a top stock pick for momentum investors?
Recent Price Trend in Kiniksa Pharmaceuticals (KNSA) is Your Friend, Here's Why
09:51am, Friday, 26'th Jul 2024
Kiniksa Pharmaceuticals (KNSA) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Sign In
Buy KNSA